PureTech Health plc (PTCHF)
OTCMKTS · Delayed Price · Currency is USD
1.550
0.00 (0.00%)
Sep 10, 2025, 8:00 PM EDT

PureTech Health Statistics

Total Valuation

PureTech Health has a market cap or net worth of 372.71 million. The enterprise value is 199.95 million.

Market Cap372.71M
Enterprise Value 199.95M

Important Dates

The last earnings date was Friday, August 22, 2025.

Earnings Date Aug 22, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 241.68M
Shares Outstanding n/a
Shares Change (YoY) -11.33%
Shares Change (QoQ) -1.00%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 167.98M

Valuation Ratios

The trailing PE ratio is 7.35.

PE Ratio 7.35
Forward PE n/a
PS Ratio 58.32
PB Ratio 1.01
P/TBV Ratio 0.99
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 3.95
EV / Sales 31.63
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -1.99

Financial Position

The company has a current ratio of 8.49, with a Debt / Equity ratio of 0.44.

Current Ratio 8.49
Quick Ratio 8.35
Debt / Equity 0.44
Debt / EBITDA n/a
Debt / FCF -1.63
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 9.44% and return on invested capital (ROIC) is -14.92%.

Return on Equity (ROE) 9.44%
Return on Assets (ROA) -12.95%
Return on Invested Capital (ROIC) -14.92%
Return on Capital Employed (ROCE) -22.90%
Revenue Per Employee 114,125
Profits Per Employee 904,964
Employee Count56
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

In the past 12 months, PureTech Health has paid 3.06 million in taxes.

Income Tax 3.06M
Effective Tax Rate 8.76%

Stock Price Statistics

The stock price has decreased by -18.34% in the last 52 weeks. The beta is 0.82, so PureTech Health's price volatility has been lower than the market average.

Beta (5Y) 0.82
52-Week Price Change -18.34%
50-Day Moving Average 1.71
200-Day Moving Average 1.76
Relative Strength Index (RSI) 24.94
Average Volume (20 Days) 1,089

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, PureTech Health had revenue of 6.39 million and earned 50.68 million in profits. Earnings per share was 0.20.

Revenue6.39M
Gross Profit -48.81M
Operating Income -117.40M
Pretax Income 34.95M
Net Income 50.68M
EBITDA -115.72M
EBIT -117.40M
Earnings Per Share (EPS) 0.20
Full Income Statement

Balance Sheet

The company has 331.28 million in cash and 163.57 million in debt, giving a net cash position of 167.71 million.

Cash & Cash Equivalents 331.28M
Total Debt 163.57M
Net Cash 167.71M
Net Cash Per Share n/a
Equity (Book Value) 369.03M
Book Value Per Share 1.56
Working Capital 303.81M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -100.30 million and capital expenditures -11,000, giving a free cash flow of -100.31 million.

Operating Cash Flow -100.30M
Capital Expenditures -11,000
Free Cash Flow -100.31M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -1,837.01%
Pretax Margin 546.82%
Profit Margin 792.96%
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PureTech Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 11.33%
Shareholder Yield n/a
Earnings Yield 13.60%
FCF Yield -26.91%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

PureTech Health has an Altman Z-Score of 1.44 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.44
Piotroski F-Score 4